Clinical Trials

    A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer (RAMP 301)

    Investigator: Aparna Kamat

    Study Coordinator: Jaya Kamath

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06072781

    Phone: 713.441.6616

    Protocol Number: PRO00038502

    Description


    This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.